Overview
- The Rutgers analysis, published June 17, 2026, used a 2025 nationally representative survey of 7,521 U.S. adults and compared 597 current GLP-1 users with 224 former users to test links to self‑reported violent acts.
- Current GLP-1 users showed about a 62% weaker association between impulsivity and violent behavior and about a 52% weaker association for alcohol-related violence, though the alcohol result was less consistent in sensitivity checks.
- Violent behavior was measured with a validated self‑report offending scale that asked about actions such as fighting, assault, and robbery rather than arrests or official criminal records.
- The authors stress the study is cross‑sectional and observational, so it cannot prove GLP-1 drugs cause lower violence risk and they call for longitudinal, administrative, and experimental studies to test timing and mechanisms.
- The paper builds on prior evidence that GLP-1 receptor agonists affect dopamine, craving, stress regulation, and impulse control, and it raises public‑health and policy questions as use of these drugs expands widely.